Abstract:Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However, a substantial proportion of HCC patients had normal AFP level even at an advanced disease status. Few studies to date had tried to explore the nature and behavior of this normal AFP HCC (N-HCC). The purpose of this study was to investigate the clinicopathological characteristics and survival outcome of N-HCC after operation. In addition, potential tumor markers for N-HCC were also sought in an attempt to augment diagnostic ability. Methods: between 2005 and 2015, patients with hepatocellular carcinoma who were treated with hepatectomy in Chang Gung Memorial Hospital Linkou branch were divided into two groups according to their preoperative serum AFP level (<15 ng/mL: NHCC; ≥15 ng/mL: abnormal AFP HCC (A-HCC)). Patient demographic data and clinicopathological variables were collected. Kaplan–Meier and Cox regression multivariate analyses were performed to identify significant risk factors for disease-free survival (DFS) and overall survival (OS) for N-HCC. ELISA and immunohistochemical (IHC) studies were employed to determine the diagnostic accuracy of various tumor markers. Results: a total of 1616 patients (78% male) who underwent liver resection for HCC were included in this study. Of them, 761 patients (47.1%) were N-HCC. N-HCC patients were significantly older with more comorbidities and less hepatitis virus infections. Furthermore, N-HCC had fewer early recurrences (49.6% vs. 60.8%, p < 0.001) and better DFS (44.6 months vs. 23.6 months, p < 0.001) and OS (94.5 months vs. 81.7 months, p < 0.001). Both ELISA and IHC studies demonstrated that glypican-3 (GPC3) would be a promising diagnostic tumor marker for N-HCC. Conclusion: N-HCC patients were significantly older and had less hepatitis virus infections or cirrhosis. Their tumors tended to be smaller, less vascular invaded, and well-differentiated. The carcinogenesis of N-HCC may thus not be identical to that of typical HCC. GPC3 would be a promising tumor marker for diagnosing N-HCC. Further study is warranted to validate our findings.

S4348 Elevated Alpha Fetoprotein of Unclear Origin: A New Subtype?

Extremely High Expression of Serum Alpha-Fetoprotein Level of Gastric Adenocarcinoma: a Rare Case with an Unexpected Well-Prognosis

Novel Characteristics of Alpha-Fetoprotein (Afp)-Producing Gastric Cancer.

An unusual cause of significantly elevated blood alpha-fetoprotein levels: a case report and literature review

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma

Elevated Serum Alpha Fetoprotein Levels Promote Pathological Progression of Hepatocellular Carcinoma

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

[Application of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma].

Poorly differentiated adenocarcinoma with signet ring cells of the gallbladder producing a high level of alpha-fetoprotein: A case report

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma

Endometrial hepatoid adenocarcinoma: a rare cause of elevated serum α-fetoprotein.

Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma.

Glycosylation Profiling of the Neoplastic Biomarker Alpha Fetoprotein through Intact Mass Protein Analysis

Alpha-fetoprotein-producing Hepatoid Adenocarcinoma of the Lung Responsive to Sorafenib after Multiline Treatment: A Case Report.

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?

Alpha-fetoprotein Still is a Valuable Diagnostic and Prognosis Predicting Biomarker in Hepatitis B Virus Infection-Related Hepatocellular Carcinoma.

Alpha-fetoprotein: Past, present, and future

Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection

Clinical significance of alpha-fetoprotein detection in HBV infectious related diseases

Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma